Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma

PURPOSE: Platinum/paclitaxel-based chemotherapy is the strategy for ovarian cancer, but chemoresistance, inherent or acquired, occurs and hinders therapy. Therefore, further understanding of the mechanisms of drug resistance and adoption of novel therapeutic strategies are urgently needed. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Ke, Dong, Yang, Wang, Liting, Duan, Yi, Yu, Jian, Sun, Ying, Bai, Min, Duan, Yourong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414939/
https://www.ncbi.nlm.nih.gov/pubmed/32801704
http://dx.doi.org/10.2147/IJN.S248667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414939/
https://www.ncbi.nlm.nih.gov/pubmed/32801704
http://dx.doi.org/10.2147/IJN.S248667

Ejemplares similares